293.85
price up icon0.49%   1.445
pre-market  Pre-market:  292.84   -1.01   -0.34%
loading
Amgen Inc stock is traded at $293.85, with a volume of 1.95M. It is up +0.49% in the last 24 hours and up +6.32% over the past month. Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$292.40
Open:
$291.745
24h Volume:
1.95M
Relative Volume:
0.87
Market Cap:
$158.20B
Revenue:
$34.76B
Net Income/Loss:
$6.62B
P/E Ratio:
24.04
EPS:
12.223
Net Cash Flow:
$10.61B
1W Performance:
-0.57%
1M Performance:
+6.32%
6M Performance:
-0.02%
1Y Performance:
-9.48%
1-Day Range:
Value
$290.97
$296.87
1-Week Range:
Value
$289.44
$297.62
52-Week Range:
Value
$253.30
$335.88

Amgen Inc Stock (AMGN) Company Profile

Name
Name
Amgen Inc
Name
Phone
(805)447-1000
Name
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Name
Employee
28,000
Name
Twitter
@amgen
Name
Next Earnings Date
2025-02-04
Name
Latest SEC Filings
Name
AMGN's Discussions on Twitter

Compare AMGN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
AMGN
Amgen Inc
293.85 157.42B 34.76B 6.62B 10.61B 12.22
Drug Manufacturers - General icon
LLY
Lilly Eli Co
812.35 734.56B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
190.85 459.75B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
229.13 406.84B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
130.26 249.96B 53.40B 13.68B 16.89B 6.8864
Drug Manufacturers - General icon
MRK
Merck Co Inc
84.70 214.06B 63.43B 16.42B 14.72B 6.4861

Amgen Inc Stock (AMGN) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-03-25 Resumed Raymond James Mkt Perform
May-20-25 Resumed Guggenheim Neutral
Apr-22-25 Resumed Cantor Fitzgerald Neutral
Dec-10-24 Resumed BofA Securities Underperform
Nov-15-24 Initiated Wolfe Research Peer Perform
Nov-14-24 Initiated Citigroup Neutral
Oct-17-24 Initiated Bernstein Outperform
Oct-14-24 Downgrade Truist Buy → Hold
Sep-27-24 Initiated Cantor Fitzgerald Overweight
Aug-07-24 Downgrade Wells Fargo Overweight → Equal Weight
May-03-24 Upgrade Barclays Underweight → Equal Weight
May-03-24 Upgrade William Blair Mkt Perform → Outperform
Mar-28-24 Resumed Raymond James Mkt Perform
Feb-07-24 Downgrade Leerink Partners Outperform → Market Perform
Dec-21-23 Upgrade Daiwa Securities Neutral → Buy
Dec-19-23 Upgrade BMO Capital Markets Market Perform → Outperform
Dec-12-23 Upgrade RBC Capital Mkts Sector Perform → Outperform
Nov-09-23 Initiated Deutsche Bank Hold
Nov-02-23 Upgrade Truist Hold → Buy
Oct-20-23 Resumed JP Morgan Neutral
Oct-17-23 Resumed Morgan Stanley Equal-Weight
Oct-11-23 Resumed BofA Securities Neutral
Sep-06-23 Initiated HSBC Securities Buy
Apr-24-23 Reiterated Oppenheimer Outperform
Mar-13-23 Upgrade Wells Fargo Equal Weight → Overweight
Feb-13-23 Reiterated Truist Buy
Nov-18-22 Initiated Credit Suisse Underperform
Oct-31-22 Downgrade Barclays Equal Weight → Underweight
Oct-11-22 Upgrade Morgan Stanley Equal-Weight → Overweight
May-23-22 Initiated SVB Leerink Mkt Perform
Feb-09-22 Reiterated Barclays Equal Weight
Feb-09-22 Reiterated Jefferies Buy
Feb-09-22 Reiterated Morgan Stanley Equal-Weight
Feb-09-22 Reiterated Oppenheimer Outperform
Feb-09-22 Reiterated Wells Fargo Equal Weight
Jan-05-22 Downgrade BofA Securities Buy → Neutral
Dec-09-21 Resumed Wells Fargo Equal Weight
Dec-06-21 Initiated Goldman Buy
Nov-19-21 Initiated BMO Capital Markets Market Perform
Sep-23-21 Downgrade Daiwa Securities Outperform → Neutral
Sep-07-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-29-20 Initiated Daiwa Securities Buy
Oct-28-20 Initiated UBS Neutral
Oct-26-20 Upgrade Raymond James Mkt Perform → Outperform
Oct-12-20 Upgrade Truist Hold → Buy
Oct-09-20 Downgrade Bernstein Outperform → Mkt Perform
Oct-09-20 Downgrade Truist Buy → Hold
Oct-08-20 Downgrade Raymond James Outperform → Mkt Perform
Apr-15-20 Resumed Guggenheim Neutral
Mar-31-20 Initiated Wolfe Research Peer Perform
Mar-30-20 Upgrade Raymond James Mkt Perform → Outperform
Mar-05-20 Upgrade BofA/Merrill Neutral → Buy
Feb-27-20 Initiated Barclays Equal Weight
Jan-31-20 Downgrade Robert W. Baird Neutral → Underperform
Jan-21-20 Upgrade Evercore ISI In-line → Outperform
Dec-24-19 Initiated Raymond James Mkt Perform
Dec-17-19 Resumed Morgan Stanley Overweight
Nov-12-19 Initiated SunTrust Buy
Nov-05-19 Upgrade Cantor Fitzgerald Neutral → Overweight
Oct-17-19 Resumed BofA/Merrill Neutral
Aug-19-19 Downgrade Mizuho Buy → Neutral
May-23-19 Upgrade Citigroup Neutral → Buy
View All

Amgen Inc Stock (AMGN) Latest News

pulisher
Oct 14, 2025

Lobbying Update: $15,000 of AMGEN INC. lobbying was just disclosed - Quiver Quantitative

Oct 14, 2025
pulisher
Oct 14, 2025

Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com

Oct 14, 2025
pulisher
Oct 14, 2025

How forex fluctuations impact Amgen Inc. (AMG0) stock2025 Trading Recap & Consistent Growth Stock Picks - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

CD40 Targeting Therapy Clinical Trials Anti CD40 Antibody Therapy Market Opportunity Assessment Insight - GlobeNewswire Inc.

Oct 14, 2025
pulisher
Oct 14, 2025

Sagespring Wealth Partners LLC Increases Stock Position in Amgen Inc. $AMGN - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Wilmington Savings Fund Society FSB Has $15.97 Million Position in Amgen Inc. $AMGN - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Morningstar Investment Management LLC Makes New $1.14 Million Investment in Amgen Inc. $AMGN - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Alpine Woods Capital Investors LLC Lowers Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Cornerstone Wealth Group LLC Acquires 12,816 Shares of Amgen Inc. $AMGN - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Amgen Inc. $AMGN Shares Bought by Vest Financial LLC - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Amgen Inc. stock daily chart insights2025 Technical Overview & Smart Investment Allocation Tips - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

(AMGN) Risk Channels and Responsive Allocation - news.stocktradersdaily.com

Oct 14, 2025
pulisher
Oct 14, 2025

Short interest data insights for Amgen Inc.July 2025 Selloffs & Risk Managed Investment Signals - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Will Amgen Inc. (AMG0) stock benefit from mergers2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Price-Driven Insight from (AMGN) for Rule-Based Strategy - news.stocktradersdaily.com

Oct 13, 2025
pulisher
Oct 13, 2025

Aanika’s Journey: Life After a Severe Asthma Diagnosis - Amgen

Oct 13, 2025
pulisher
Oct 13, 2025

Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention - Yahoo Finance

Oct 13, 2025
pulisher
Oct 13, 2025

Understanding Momentum Shifts in (AMGN) - news.stocktradersdaily.com

Oct 13, 2025
pulisher
Oct 13, 2025

Amgen Inc. $AMGN Shares Bought by Sequoia Financial Advisors LLC - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

Concurrent Investment Advisors LLC Boosts Position in Amgen Inc. $AMGN - MarketBeat

Oct 13, 2025
pulisher
Oct 12, 2025

Reflecting On Therapeutics Stocks’ Q2 Earnings: Amgen (NASDAQ:AMGN) - The Globe and Mail

Oct 12, 2025
pulisher
Oct 12, 2025

How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Oct 12, 2025
pulisher
Oct 12, 2025

(AMGN) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com

Oct 12, 2025
pulisher
Oct 12, 2025

Will Amgen Inc. (AMG0) stock deliver stable dividendsJuly 2025 Review & Technical Pattern Recognition Alerts - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Keener Financial Planning LLC Raises Stake in Amgen Inc. $AMGN - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

With 81% ownership, Amgen Inc. (NASDAQ:AMGN) boasts of strong institutional backing - Yahoo Finance

Oct 12, 2025
pulisher
Oct 12, 2025

Natural Investments LLC Has $1.05 Million Stake in Amgen Inc. $AMGN - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Amgen Inc. $AMGN Shares Acquired by Cwm LLC - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Vanguard Personalized Indexing Management LLC Acquires 8,411 Shares of Amgen Inc. $AMGN - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Sather Financial Group Inc Grows Stake in Amgen Inc. $AMGN - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Amgen Inc. $AMGN Shares Acquired by Fifth Third Wealth Advisors LLC - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Richardson Financial Services Inc. Has $66,000 Position in Amgen Inc. $AMGN - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Assessing Amgen (AMGN) Valuation as Shares Show Renewed Momentum in the Biotech Landscape - simplywall.st

Oct 12, 2025
pulisher
Oct 12, 2025

Will Amgen Inc. stock recover after recent drop2025 Support & Resistance & Consistent Profit Alerts - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Thompson Investment Management Inc. Decreases Position in Amgen Inc. $AMGN - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Cyndeo Wealth Partners LLC Has $6.97 Million Holdings in Amgen Inc. $AMGN - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Commerzbank Aktiengesellschaft FI Sells 3,381 Shares of Amgen Inc. $AMGN - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Amgen Inc. $AMGN Stock Holdings Lowered by Drucker Wealth 3.0 LLC - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Lmcg Investments LLC Sells 2,659 Shares of Amgen Inc. $AMGN - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Horizon Bancorp Inc. IN Purchases New Shares in Amgen Inc. $AMGN - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

First Fiduciary Investment Counsel Inc. Buys 1,069 Shares of Amgen Inc. $AMGN - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Amgen (NASDAQ:AMGN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

Is Amgen Inc. (AMGN) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom? - MSN

Oct 10, 2025
pulisher
Oct 10, 2025

AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing - Bioprocess Online

Oct 10, 2025
pulisher
Oct 10, 2025

Market reaction to Amgen Inc.’s recent newsMarket Risk Summary & Technical Confirmation Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Responsive Playbooks and the AMGN Inflection - news.stocktradersdaily.com

Oct 10, 2025
pulisher
Oct 10, 2025

Quantitative breakdown of Amgen Inc. recent moveMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Amgen Inc. (AMG0) stock cheap by valuation metricsTrade Volume Summary & Verified Chart Pattern Trade Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Amgen Inc. (AMG0) stock outperform energy sector in 20252025 Winners & Losers & AI Driven Stock Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Mainstay Capital Management LLC ADV Increases Position in Amgen Inc. $AMGN - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Amgen Inc. $AMGN Stake Boosted by Copperwynd Financial LLC - MarketBeat

Oct 10, 2025

Amgen Inc Stock (AMGN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$118.48
price up icon 0.23%
drug_manufacturers_general PFE
$24.52
price down icon 0.85%
drug_manufacturers_general NVO
$56.66
price down icon 1.46%
drug_manufacturers_general SNY
$49.22
price up icon 0.86%
drug_manufacturers_general MRK
$84.70
price down icon 1.17%
Cap:     |  Volume (24h):